Table 3.
Potential drug-drug interactions according to their severity, documentation and clinical value
| Frequency (%) | |
|---|---|
| Severity | |
| Contraindicated | 9 (9.18) |
| Important | 41 (41.84) |
| Moderate | 46 (46.94) |
| Secondary | 2 (2.04) |
| Documentation | |
| Excellent | 26 (26.53) |
| Good | 21 (21.43) |
| Fair | 51 (52.04) |
| Clinical value* | |
| 1 | 50 (51.02) |
| 2 | 46 (46.94) |
| 3 | 2 (2.04) |
1: avoid combinations; 2: usually avoid combinations; 3: minimize the risk.